Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
ICI combinations and monotherapy showed improved clinical outcomes compared to chemotherapy. Adjusted analyses indicated no significant difference in outcomes between ICI monotherapy and ICI combinations.
In summary, the study highlights the growing adoption of ICI-based treatments in clinical practice and their association with improved outcomes for patients with CD274 (Programmed death-ligand 1 (PD-L1) positive metastatic Non-Small-Cell Lung Carcinoma (NSCLC)
Single-agent immune checkpoint inhibitors are now standard of care for advanced [Non-Small-Cell Lung Carcinoma (NSCLC)](brain://j0-uv_ewnUKCSIhKn…